Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study

BACKGROUND: Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients must be vaccinated against SARS-CoV-2 as quickly as possible after transplantation. The difficulty in obtaining recommended SARS-CoV-2 vaccines for allo-HSCT recipients motivated us to utilize an accessible and affordab...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkhordar, Maryam, Chahardouli, Bahram, Biglari, Alireza, Ahmadvand, Mohammad, Bahri, Tanaz, Alaeddini, Farshid, Sharifi Aliabadi, Leyla, Noorani, Seied Saeid, Bagheri Amiri, Fahimeh, Biglari, Mohammad, Shemshadi, Mohammad Reza, Ghavamzadeh, Ardeshir, Vaezi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154585/
https://www.ncbi.nlm.nih.gov/pubmed/37153556
http://dx.doi.org/10.3389/fimmu.2023.1169666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154585/
https://www.ncbi.nlm.nih.gov/pubmed/37153556
http://dx.doi.org/10.3389/fimmu.2023.1169666

Ejemplares similares